NCT04676893View on ClinicalTrials.gov

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388 in Healthy Subjects

PHASE1UnknownINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 26, 2021

Primary Completion Date

May 11, 2021

Study Completion Date

May 18, 2021

Conditions
Chronic Hepatitis b
Interventions
DRUG

D418 Tab.

1T

DRUG

CKD-388 Tab.

1T

Trial Locations (1)

Unknown

Korea University Anam Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT04676893 - Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388 in Healthy Subjects | Biotech Hunter | Biotech Hunter